Rchr
J-GLOBAL ID：202201014434750379
Update date: Nov. 17, 2024
Wakatsuki Takeru
ワカツキ タケル | Wakatsuki Takeru
Affiliation and department：
Research keywords (2)：
バイオマーカー
, HER2陽性胃癌
Research theme for competitive and other funds (3)：
- 2019 - 2022 Changes in the immunological profile of gastric cancer stem cells due to irradiation
- 2018 - 2022 抗VEGFR2抗体投与後早期のVEGF-A上昇の臨床的意義と新たな治療戦略の開発
- 2015 - 2018 Clinical impact of intratumoral HER2 heterogeneity on trastuzumab eficacy
Papers (92)：
-
Hirokazu Shoji, Chie Kudo-Saito, Kengo Nagashima, Hiroshi Imazeki, Kai Tsugaru, Naoki Takahashi, Takeshi Kawakami, Yusuke Amanuma, Takeru Wakatsuki, Naohiro Okano, et al. Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study). Journal for immunotherapy of cancer. 2024. 12. 11
-
Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami, Akira Ooki, Atsuo Takashima, Takeru Wakatsuki, Hidekazu Hirano, Izuma Nakayama, Kota Ouchi, Ryoichi Sawada, et al. Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study. Journal of cancer research and clinical oncology. 2024. 150. 7. 369-369
-
Takeru Wakatsuki, Naoki Ishizuka, Shuichi Hironaka, Keiko Minashi, Shigenori Kadowaki, Masahiro Goto, Hirokazu Shoji, Hidekazu Hirano, Izuma Nakayama, Hiroki Osumi, et al. Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab. International journal of clinical oncology. 2024. 29. 6. 801-812
-
Ryo Takahashi, Hiroki Osumi, Takeru Wakatsuki, Noriko Yamamoto, Senzo Taguchi, Izuma Nakayama, Akira Ooki, Mariko Ogura, Daisuke Takahari, Keisho Chin, et al. Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan. International journal of clinical oncology. 2024
-
Jin Lee, Tetsuo Mashima, Naomi Kawata, Noriko Yamamoto, Shun Morino, Saori Inaba, Ayane Nakamura, Koshi Kumagai, Takeru Wakatsuki, Kengo Takeuchi, et al. Pharmacological targeting of histone H3K27 acetylation/BRD4-dependent induction of ALDH1A3 for early-phase drug tolerance of gastric cancer. Cancer research communications. 2024
ｍore...
MISC (251)：
-
木村優花, 川上和宜, 中村匡志, 横川貴志, 清水久範, 小林一男, 青山剛, 鈴木亘, 羽鳥正浩, 鈴木賢一, et al. Evaluation of the Leftover Capecitabine Tablets in Adjuvant CAPOX Chemotherapy for Gastric Cancer. YAKUGAKU ZASSHI (Web). 2023. 143. 12
-
山口研成, 篠崎英司, 下嵜啓太郎, 大隅寛樹, 中山厳馬, 若槻尊, 小倉真理子, 大木暁, 高張太亮, 陳勁松. Position of immune checkpoint inhibitor in advanced colorectal cancer. 月刊消化器・肝臓内科. 2022. 11. 3. 297-302
-
三梨 桂子, 若槻 尊, 石塚 直樹, 廣中 秀一, 門脇 重憲, 後藤 昌弘, 庄司 広和, 平野 秀和, 中山 厳馬, 大隅 寛木, et al. HER2陽性胃癌トラスツズマブ併用化学療法における血清HER2細胞外ドメインの探索的解析(Exploratory Analysis of serum HER2 Extracellular Domain(ECD) in HER2 Positive Gastric Cancer). 日本胃癌学会総会記事. 2022. 94回. 256-256
-
山口研成, 篠崎英司, 下嵜啓太郎, 大隅寛木, 中山厳馬, 小倉真理子, 若槻尊, 大木暁, 高張大亮, 陳勁松. Chemotherapy for advanced colorectal cancer. 医学と薬学. 2022. 79. 3. 339-348
-
HATORI Masahiro, NAKAYAMA Izuma, NAKAMURA Masashi, KOBAYASHI Kazuo, OOKI Akira, OGURA Mariko, OSUMI Hiroki, SHIMOZAKI Keitaro, WAKATSUKI Takeru, SHINOZAKI Eiji, et al. Clinical experiences of combination therapy with cisplatin for the older-aged esophageal cancer patients. 日本臨床腫瘍学会学術集会(CD-ROM). 2022. 19th
ｍore...
Return to Previous Page
